Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_assertion type Assertion NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_head.
- NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_assertion description "[Collectively, our data indicate that ERBB2-mediated breast cancer progression requires ?-catenin signaling and can be therapeutically targeted by selective ?-catenin/CBP inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_provenance.
- NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_assertion evidence source_evidence_literature NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_provenance.
- NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_assertion SIO_000772 23720052 NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_provenance.
- NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_assertion wasDerivedFrom befree-20150227 NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_provenance.
- NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_assertion wasGeneratedBy ECO_0000203 NP668412.RAaoInMm2hYO7jcRbwYMao4H1FHuqWCoCx31rJ6yHNnJc130_provenance.